Related Experiment Videos
Immunological monitoring and clinical trials of biological response modifiers
W C Kopp1, J T Holmlund, W J Urba
1Program Resources Inc., National Cancer Institute, Frederick Cancer Research and Development Center, MD, USA.
Cancer Chemotherapy and Biological Response Modifiers
|January 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Clinical impact for advanced non-small-cell lung cancer patients tested using comprehensive genomic profiling at a large USA health care system.
ESMO real world data and digital oncology·2026
Major pathologic response on biopsy (MPRbx) in patients with advanced melanoma treated with anti-PD-1: evidence for an early, on-therapy biomarker of response.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
Randomized phase II trial of docetaxel plus prednisone in combination with placebo or AT-101, an oral small molecule Bcl-2 family antagonist, as first-line therapy for metastatic castration-resistant prostate cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2011
Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2005
Correlation and diagnostic accuracy of kappa free light chain index and Oligoclonal bands in multiple sclerosis and other neurological diseases.
Multiple sclerosis and related disorders·2026
Bronchoalveolar Lavage Fluid Cellularity Reflects Peripheral Cytopenias and Fungal Burden but Not Short-Term Outcomes in Invasive Pulmonary Aspergillosis.
The Journal of infectious diseases·2026
Choroidal Tuberculosis in Miliary Disease: A Multimodal Imaging Spectrum Across Iatrogenic and Disease-Mediated Immunosuppression.
Ocular immunology and inflammation·2026